$1,175,683,451

Department of Veterans Affairs·Department of Veterans Affairs

to MCKESSON CORPORATION

veteransexpired

WORK BEGAN2026-03-01·LATEST ACTION2026-05-01·SOURCEUSASPENDING·SOURCE IDCONT_AWD_36C24026K1006_3600_36W79720D0001_3600

Award description

EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MARCH

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Supplies pharmaceuticals to VA medical facilities nationwide through McKesson's prime vendor distribution network for fiscal year 2026.

Sub-sectors

va-pharmaceutical-supplyprime-vendor-contract

Why this matters

Ensures reliable, cost-effective drug delivery to millions of veterans across the VA health system; a critical supply-chain contract for continuity of care.

Supply-chain signal

McKesson acts as the central pharmaceutical distributor for VA; this contract signals demand for bulk pharmaceutical logistics, warehousing, and just-in-time delivery capabilities.

Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-05-17. Cost: $0.002740.

Period of performance

Start

2026-03-01

End

2026-03-31

Status

expired91 days ago

Recipient

MCKESSON CORPORATION

UEI S1RUKWWRYFL6

View full profile →

Other awards from this recipient

See all →

2026-05-29EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 APRIL$1.2B

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_36C24026K1006_3600_36W79720D0001_3600.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.